AP Pharma Inc. (HRTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Jan-24 9:03 PM
View: 
Johnson Craig A
Director
AP Pharma Inc. (HRTX) 19-Jan-24Grant 13,948----27%
51.87K to 65.82K
19-Jan-24 9:05 PM
View: 
Christian Waage
Director
AP Pharma Inc. (HRTX) 19-Jan-24Grant 13,948----27%
52.23K to 66.18K
19-Jan-24 9:04 PM
View: 
Morgan Adam
Director
AP Pharma Inc. (HRTX) 19-Jan-24Grant 13,948----< 1%
7.02M to 7.04M
19-Jan-24 9:02 PM
View: 
Dissanaike Sharmila
Director
AP Pharma Inc. (HRTX) 19-Jan-24Grant 13,948----25%
55.28K to 69.23K
19-Jan-24 9:04 PM
View: 
Rodriguez Susan
Director
AP Pharma Inc. (HRTX) 19-Jan-24Grant 13,948----25%
55.28K to 69.23K
16-Jan-24 5:19 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-24Payment of Exercise 756$2.15$1,625.40(1%)
56.66K to 55.91K
16-Jan-24 5:19 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-24Option Exercise 1,841----3%
54.82K to 56.66K
21-Nov-23 12:19 PM
View: 
Forbes William P
EVP, Chief Development Officer
AP Pharma Inc. (HRTX) 17-Nov-23Private Purchase 25,000$1.09$27,250.0046%
54.0K to 79.0K
17-Nov-23 12:37 PM
View: 
Collard Craig A
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 16-Nov-23Private Purchase 150,000$0.92$137,970.00411%
36.5K to 186.5K
20-Nov-23 10:07 AM
View: 
Forbes William P
EVP, Chief Development Officer
AP Pharma Inc. (HRTX) 16-Nov-23Private Purchase 50,000$0.94$46,995.001250%
4.0K to 54.0K
17-Nov-23 12:36 PM
View: 
Duarte Ira
EVP, Chief Financial Officer
AP Pharma Inc. (HRTX) 16-Nov-23Private Purchase 85,000$0.89$75,599.00100%
0 to 85.0K
17-Oct-23 7:57 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Oct-23Payment of Exercise 860$0.72$619.20(2%)
55.68K to 54.82K
17-Oct-23 7:57 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Oct-23Option Exercise 2,484----5%
53.2K to 55.68K
24-Aug-23 4:09 PM
View: 
Collard Craig A
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 22-Aug-23Payment of Exercise 692$1.65$1,141.80(2%)
37.19K to 36.5K
17-Oct-23 7:57 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 25-Jul-23Option Exercise 42,631----168%
25.31K to 67.94K
17-Oct-23 7:57 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 25-Jul-23Payment of Exercise 14,743$1.51$22,261.90(22%)
67.94K to 53.2K
25-Jul-23 4:22 PM
View: 
Morgan Adam
Director
AP Pharma Inc. (HRTX) 21-Jul-23Private Purchase 2,486,740$1.37$3,406,840.0055%
4.54M to 7.02M
17-Jul-23 5:51 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jul-23Payment of Exercise 2,012$1.31$2,635.72(6%)
35.77K to 33.75K
17-Jul-23 5:51 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jul-23Option Exercise 2,485----10%
23.68K to 26.17K
17-Jul-23 5:51 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jul-23Payment of Exercise 860$1.31$1,126.60(3%)
26.17K to 25.31K
17-Jul-23 5:51 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jul-23Option Exercise 5,814----19%
29.95K to 35.77K
24-May-23 5:04 PM
View: 
Collard Craig A
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 22-May-23Payment of Exercise 691$1.45$1,001.95(2%)
37.88K to 37.19K
17-Apr-23 5:27 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Apr-23Option Exercise 2,484----11%
22.06K to 24.55K
17-Apr-23 5:27 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Apr-23Payment of Exercise 860$2.88$2,476.80(4%)
24.55K to 23.68K
17-Apr-23 5:28 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Apr-23Option Exercise 5,814----22%
26.15K to 31.96K
17-Apr-23 5:26 PM
View: 
Manhard Kimberly
EVP, Drug Development
AP Pharma Inc. (HRTX) 13-Apr-23Payment of Exercise 1,417$2.88$4,080.96(5%)
29.75K to 28.33K
17-Apr-23 5:27 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Apr-23Payment of Exercise 2,012$2.88$5,794.56(4%)
48.66K to 46.65K
17-Apr-23 5:28 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Apr-23Payment of Exercise 2,012$2.88$5,794.56(6%)
31.96K to 29.95K
17-Apr-23 5:26 PM
View: 
Manhard Kimberly
EVP, Drug Development
AP Pharma Inc. (HRTX) 13-Apr-23Option Exercise 5,814----24%
23.93K to 29.75K
17-Apr-23 5:27 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Apr-23Option Exercise 5,814----14%
42.85K to 48.66K
24-Feb-23 7:20 PM
View: 
Morgan Adam
Director
AP Pharma Inc. (HRTX) 22-Feb-23Grant 37,879----< 1%
4.5M to 4.54M
17-Jan-23 5:35 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-23Option Exercise 2,485----12%
20.59K to 23.07K
17-Jan-23 5:34 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jan-23Payment of Exercise 2,012$3.17$6,378.04(8%)
25.95K to 23.93K
17-Jan-23 5:34 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jan-23Option Exercise 5,814----29%
20.13K to 25.95K
17-Jan-23 5:36 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jan-23Option Exercise 5,814----15%
39.04K to 44.86K
17-Jan-23 5:37 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jan-23Payment of Exercise 2,012$3.17$6,378.04(7%)
28.16K to 26.15K
17-Jan-23 5:37 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jan-23Option Exercise 5,814----26%
22.35K to 28.16K
17-Jan-23 5:35 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-23Payment of Exercise 1,013$3.17$3,211.21(4%)
23.07K to 22.06K
17-Jan-23 5:36 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jan-23Payment of Exercise 2,012$3.17$6,378.04(4%)
44.86K to 42.85K
17-Jan-23 5:36 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jan-23Payment of Exercise 5,219$3.17$16,544.20(3%)
183.21K to 177.99K
17-Jan-23 5:36 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jan-23Option Exercise 19,767----12%
163.44K to 183.21K
20-Dec-22 5:19 PM
View: 
Davis Stephen
Director
AP Pharma Inc. (HRTX) 16-Dec-22Grant 38,580----287%
13.45K to 52.03K
20-Dec-22 5:20 PM
View: 
Dissanaike Sharmila
Director
AP Pharma Inc. (HRTX) 16-Dec-22Grant 38,580----231%
16.7K to 55.28K
20-Dec-22 5:21 PM
View: 
Rodriguez Susan
Director
AP Pharma Inc. (HRTX) 16-Dec-22Grant 38,580----231%
16.7K to 55.28K
20-Dec-22 5:20 PM
View: 
Johnson Craig A
Director
AP Pharma Inc. (HRTX) 16-Dec-22Grant 38,580----290%
13.29K to 51.87K
20-Dec-22 5:22 PM
View: 
Christian Waage
Director
AP Pharma Inc. (HRTX) 16-Dec-22Grant 38,580----283%
13.65K to 52.23K
17-Jan-23 5:36 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 31-Oct-22Acquisition (other) 1,655$3.27$5,415.991%
161.79K to 163.44K
17-Jan-23 5:34 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 31-Oct-22Acquisition (other) 1,655$3.27$5,415.999%
18.48K to 20.13K
17-Jan-23 5:37 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 31-Oct-22Acquisition (other) 1,654$3.27$5,412.718%
20.69K to 22.35K
17-Oct-22 4:38 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 5,814----34%
16.89K to 22.71K